JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mochizuki, T.
Right arrow Articles by Tamaki, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mochizuki, T.
Right arrow Articles by Tamaki, N.

Detection of Apoptotic Tumor Response In Vivo After a Single Dose of Chemotherapy with 99mTc-Annexin V

Takafumi Mochizuki, MD1, Yuji Kuge, PhD2, Songji Zhao, MD3, Eriko Tsukamoto, MD3, Masuo Hosokawa, MD4, H. William Strauss, MD5, Francis G. Blankenberg, MD6, Jonathan F. Tait, PhD7 and Nagara Tamaki, MD3

1 Department of Radiology, Nikko Memorial Hospital, Muroran, Japan
2 Department of Tracer Kinetics, Graduate School of Medicine, Hokkaido University, Sapporo, Japan
3 Department of Nuclear Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan
4 Department of Pathological Oncology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan
5 Department of Nuclear Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York
6 Division of Nuclear Medicine, Department of Radiology, Stanford University School of Medicine, Stanford, California
7 Department of Laboratory Medicine, University of Washington, Seattle, Washington



View larger version (17K):

[in a new window]
 
FIGURE 1. Uptake of 99mTc-annexin V (A) and number of TUNEL-positive cells (B) in tumor. Uptake of 99mTc-annexin V and number of TUNEL-positive cells were significantly higher in treated tumor than in control tumor. Control = control rats; treated = rats treated with cyclophosphamide (150 mg/kg intraperitoneally).

 


View larger version (149K):

[in a new window]
 
FIGURE 2. TUNEL staining (x200) of tumor specimens in control rats (A) and treated rats (B). Cells stained brown were considered TUNEL positive. TUNEL-positive cells were observed in tumor specimens obtained from both control and treated rats.

 


View larger version (17K):

[in a new window]
 
FIGURE 3. Correlation of uptake of 99mTc-annexin V and number of TUNEL-positive cells in tumor. Tumor uptake of 99mTc-annexin V significantly correlated with number of TUNEL-positive cells in tumor. (Uptake of 99mTc-annexin V) = 0.025 + 1.397 x 10-4 x (number of TUNEL-positive cells); r = 0.712; P < 0.001. {circ} = control rats; {square} = treated rats.

 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.